Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Alexion uses priority review voucher for Soliris follow-up

Alexion uses priority review voucher for Soliris follow-up Files ravulizumab for paroxysmal nocturnal haemoglobinuria. Alexion is pulling out all the stops to get speedy approval for a follow-up to its rare blood disorder therapy Soliris, using a coveted ... The company has filed ravulizumab ( ALXN1210) for

Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more gMG). It also unveiled positive top-line data from its Phase III trial of ALXN1210, a long-acting form of its flagship treatment Soliris. ... ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria (PNH) need only be administered once every eight

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy has a long way to go before it bears comparison with Soliris’ $3.1bn turnover. ... Since then it has added to its patents for Soliris and is claiming protection from generic competition out to 2027, although that could of course be challenged in the

Alexion's Soliris gets US approval for myasthenia gravis

Alexion's Soliris gets US approval for myasthenia gravis New neurology indication could contribute $1.2bn to sales, says analysts. Alexion has finally claimed FDA approval for its complement inhibitor Soliris in myasthenia gravis (MG), potentially adding another $1bn-plus ... The US regulator has approved

Germany will be first EU launch market for new Soliris indication

Germany will be first EU launch market for new Soliris indication Soliris available that has demonstrated in clinical studies that it improves patients’ symptoms and their ability to undertake daily activities.”. ... However, Soliris does come with a boxed warning of ‘life-threatening’ and ‘fatal’

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics